Asaarna Pharmaceuticals Private Limited
Pharmaceutical trading company incorporated in 2020 with registered office in Lucknow, UP.
2020 | Lucknow, Uttar Pradesh (India) | Active
Asaarna Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.75 M
- Revenue Growth 526.47%
- Profit Growth 220.46%
- Ebitda -67.72%
- Net Worth 166.52%
- Total Assets 80.23%
About Asaarna Pharmaceuticals
Asaarna Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 October 2020 (Four years and four months 17 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.75 M.
Amit Tiwari and Sonal Mishra serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290UP2020PTC136007
- Company No.
136007
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Asaarna Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Tiwari  | Director | 12-Oct-2020 | Current |
| Sonal Mishra | Director | 12-Oct-2020 | Current |
Financial Performance of Asaarna Pharmaceuticals.
Asaarna Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 526.47% increase. The company also saw a substantial improvement in profitability, with a 220.46% increase in profit. The company's net worth Soared by an impressive increase of 166.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asaarna Pharmaceuticals?
In 2021, Asaarna Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Asnarayan Enterprises Private Limited
Amit Tiwari and Sonal Mishra are mutual person
- Aarna Business Private Limited
Amit Tiwari and Sonal Mishra are mutual person
Charges (Loans)
Open Charges
₹2.75 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2022 | Hdfc Bank Limited | ₹2.75 M | Open |
How Many Employees Work at Asaarna Pharmaceuticals?
Asaarna Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asaarna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asaarna Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.